Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | PRKCI | P41743 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | PPARD | Q03181 | 2/20 | 0.49 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.49 |
| ▸ | CYSLTR2 | Q9NS75 | 13/20 | 0.48 |
| ▸ | CYSLTR1 | Q9Y271 | 13/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30736074 | 1.00 | CYP1A2 (0.50) | CYP1A2CYP2C9PRKCIALDH1A1CYP2D6 | |
| SCHEMBL7041417 | 0.95 | CYP1A2 (0.47) | CYP1A2CYP2C9PRKCIALDH1A1CYP2D6 | |
| SCHEMBL10975179 | 0.89 | CYP1A2 (0.48) | CYP1A2CYP2C9PRKCIALDH1A1CYP2D6 | |
| SCHEMBL9121697 | 0.88 | CYP1A2 (0.47) | CYP1A2CYP2C9PRKCIALDH1A1CYP2D6 | |
| SCHEMBL9814053 | 0.86 | TYR (0.49) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL9814064 | 0.86 | TYR (0.49) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL9814051 | 0.86 | TYR (0.49) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL10726758 | 0.85 | SELL (0.53) | CYP1A2CYP2C9PRKCIALDH1A1PPARG | |
| SCHEMBL2009246 | 0.85 | ALDH1A1 (0.53) | CYP1A2CYP2C9PRKCIALDH1A1CYP2D6 | |
| SCHEMBL13452821 | 0.84 | PPARG (0.48) | CYP1A2CYP2C9PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12269909-B2 | Polymer composition and a method of preparing a polymer resin | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-04-08 | — | — | US | claimed |
| US-20220041781-A1 | A Polymer Composition and a Method of Preparing a Polymer Resin | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-02-10 | — | — | US | claimed |
| WO-2020130941-A1 | A POLYMER COMPOSITION AND A METHOD OF PREPARING A POLYMER RESIN | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-06-25 | — | — | WO | claimed |
| EP-1817301-B1 | POTENTIATORS OF GLUTAMATE RECEPTORS | LILLY CO ELI (US) | 2012-02-01 | — | — | EP | claimed |
| US-7598423-B2 | Potentiators of glutamate receptors | ELI LILLY AND COMPANY (US) | 2009-10-06 | — | — | US | claimed |
| US-20080139505-A1 | Potentiators Of Glutamate Receptors | ARRAY BIOPHARMA, INC. | 2008-06-12 | — | — | US | claimed |
| EP-1817301-A1 | POTENTIATORS OF GLUTAMATE RECEPTORS | ELI LILLY AND COMPANY (US) | 2007-08-15 | — | — | EP | claimed |
| WO-2006057870-A1 | POTENTIATORS OF GLUTAMATE RECEPTORS | ELI LILLY AND COMPANY (US) | 2006-06-01 | — | — | WO | claimed |
| EP-1086079-B1 | DERIVATIVES OF HYDROXYPHENYLSULFANYLBENZOIC AND HYDROXYPHENYLSULFANYLARYLACETIC ACIDS | LECIVA A S (CZ) | 2003-05-07 | — | — | EP | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-6303612-B1 | USED AS ANTIINFLAMMATORY AND/OR ANTIASTHMATIC AGENTS | LECIVA, A.S. (CZ) | 2001-10-16 | — | — | US | claimed |
| EP-1086079-A1 | DERIVATIVES OF HYDROXYPHENYLSULFANYLBENZOIC AND HYDROXYPHENYLSULFANYLARYLACETIC ACIDS | Leciva, A.S. (CZ) | 2001-03-28 | — | — | EP | claimed |
| WO-1999067208-A1 | DERIVATIVES OF HYDROXYPHENYLSULFANYLBENZOIC AND HYDROXYPHENYLSULFANYLARYLACETIC ACIDS | LECIVA, A.S. (CZ) | 1999-12-29 | — | — | WO | claimed |
| EP-0242230-B1 | Pyrido [1,2-a] pyrimidine derivatives | TOKYO TANABE COMPANY LIMITED (JP) | 1990-10-03 | — | — | EP | claimed |
| EP-0217673-B1 | Pyrido [1,2-a]pyrimidine derivatives | TOKYO TANABE COMPANY LIMITED (JP) | 1989-12-27 | — | — | EP | claimed |
| EP-0242230-A2 | Pyrido [1,2-a] pyrimidine derivatives | TOKYO TANABE COMPANY LIMITED (JP) | 1987-10-21 | — | — | EP | claimed |
| EP-0217673-A1 | Pyrido [1,2-a]pyrimidine derivatives | TOKYO TANABE COMPANY LIMITED (JP) | 1987-04-08 | — | — | EP | claimed |
| JP-1193223-A | — | — | None | — | — | JP | disclosed |
| US-4136192-A | ANTIALLERGENS | BEECHAM GROUP LIMITED (GB) | 1979-01-23 | — | — | US | disclosed |
| US-4133889-A | ANAPHYLAXIS ANTAGONISTS | FISONS, LTD. (GB) | 1979-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139505-A1 | Potentiators Of Glutamate Receptors | GRM1, GRIN1, GRM2 | CYP1A2 1022/4885CYP2C9 890/4885PRKCI 2743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.